Efficacy of 1-week ranitidine-bismuth-citrate (RBC)-based triple therapy for eradication of Helicobacter pylori infection

被引：0
作者：
Savarino, V [1 ]
Vigneri, S
机构：
[1] Univ Genoa, Dept Med Interna & Specialita Med, Genoa, Italy
[2] Univ Palermo, Ist Med Interna & Geriatria, Palermo, Italy
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 1999年 / 13卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1251 / 1251
页数：1
相关论文
共 50 条
[31]   Double therapy with ranitidine bismuth citrate (RBC) and clarithromycin during two weeks, has lower efficacy than triple therapy with RBC, clarithromycin and amoxicillin during one week in the eradication of H. pylori infection. [J].
Hergueta, P ;
Rojas, M ;
Romero, R ;
Gomez, BJ ;
Pellicer, FJ ;
Herrerias, JM .
GASTROENTEROLOGY, 2000, 118 (04) :A1245-A1245
[32]   Effectiveness of a ranitidine bismuth citrate triple therapy for treating Helicobacter pylori. [J].
Smoot, DT ;
Hinds, T ;
Ashktorab, H ;
Jagtap, J ;
Kim, KS .
GASTROENTEROLOGY, 1998, 114 (04) :A290-A290
[33]   Treatment of Helicobacter pylori infection -: Triple regimen based on ranitidine bismuth citrate could be solution [J].
Savarino, V ;
Neri, M ;
Vigneri, S .
BMJ-BRITISH MEDICAL JOURNAL, 2000, 320 (7248) :1541-1541
[34]   Ranitidine bismuth citrate in the treatment of Helicobacter Pylori infection [J].
Delgado, PH ;
Feria, MR ;
Castro, RR ;
Olivares, FJM ;
Rodríguez, BG ;
Bautista, FJP ;
Gutiérrez, JMH .
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2002, 94 (01) :22-24
[35]   Ranitidine bismuth citrate (RBC) based triple therapy for 7 days is more effective than RBC plus clarithromycin for 14 days in dyspeptic patients with Helicobacter pylori infection [J].
Cestari, R .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1998, 12 (10) :991-996
[36]   One-week therapy with pantoprazole versus ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication [J].
Gisbert, JP ;
Carpio, D ;
Marcos, S ;
Gisbert, JL ;
Grávalos, RG ;
Pajares, JM .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2000, 12 (05) :489-495
[37]   Lansoprazole or ranitidine bismuth citrate based triple therapies for Helicobacter pylori eradication: Results of an open randomized study [J].
Spadaccini, A ;
DeFanis, C ;
Sciampa, G ;
Pantaleone, U ;
DiVirgilio, M ;
Pizzicannella, G .
GUT, 1997, 41 :A212-A212
[38]   Retreatment after failure of Helicobacter pylori eradication:: Quadruple vs ranitidine bismuth citrate two-week therapy [J].
Di Mario, F ;
Salandin, S ;
Dal Bo', N ;
Pilotto, A ;
Franceschi, M ;
Grassi, SA ;
De Bastiani, R ;
Leandro, G ;
Germaná, B ;
Battaglia, G .
GUT, 1999, 45 :A115-A115
[39]   Eradication of Helicobacter pylori using one-week therapy combining ranitidine bismuth citrate with two antibiotics. [J].
Savarino, V ;
Mansi, C ;
Mele, MR ;
Bisso, G ;
Mela, GS ;
Saggioro, A ;
Caroli, M ;
Vigneri, S ;
Termini, R ;
Olivieri, A ;
Tosatto, R ;
Celle, G .
GASTROENTEROLOGY, 1997, 112 (04) :A280-A280
[40]   Lansoprazole or ranitidine bismuth citrate based triple therapies for Helicobacter pylori eradication: Results of an open randomized study [J].
Spadaccini, A ;
DeFanis, C ;
Sciampa, G ;
Pantaleone, U ;
DiVirgilio, M ;
Pizzicannella, G .
GUT, 1997, 41 :A105-A105
12345